curriculum vitae p patrick basu, md, mrcp, agaf
TRANSCRIPT
Curriculum Vitae
P Patrick Basu, MD, MRCP, AGAF
Personal Information
Address:
Home: 5 Circle Hill Road, Pelham Manor, NY 10803
Office: 5 Station Square, Forest Hills, NY 11375,
718-897-0584 (phone)
718-896-5571 (fax)
Email: [email protected]
Web-site: www.gastrospecialist.com
Citizenship: U.S.A.
Licensure
Available Upon Request
Certification
Diplomat of ABIM in Internal Medicine
Diplomat of ABIM in Gastroenterology
Memberships
American College of Gastroenterological (AGA) Legacy Society
Fellow of the Royal Society of Medicine, London, UK
American Gastroenterological Association (AGA)
American Neurogastroenterology and Motility Society
Member of the Royal College of Physicians London ( UK)
Fellow of the American gastroenterological Association (FAGA)
Association for the Study of Liver Disease (AASLD)
Cohn’s and Colitis Foundation of America
American College of Physicians (ACP)
International Liver Transplant Society
Colon Cancer Foundation of America
American Liver Foundation Advisory Board Member, NY Chapter
National Pancreatic Foundation
Functional Brain-Gut Research
American Society For Gastrointestinal Endoscopy( ASGE)
Hepatitis B organization of America
British Liver Trust
American Medical Association ( AMA)
American college of Gastroenterology (ACG)
Academy of Science, NY
P Patrick Basu CV
2
Hospital Affiliations
Assistant Clinical Professor of Medicine
Columbia University College of Physicians & Surgeons, NY, NY
Division Chief of Gastroenterology and Gastrointestinal Endoscopy
Forest Hills Hospital (North Shore University Hospital at Forest Hills),
Forest Hills, New York
Director of Medical Education & Clinical Research
Forest Hills Hospital (North Shore University Hospital at Forest Hills),
Forest Hills, New York
2007 - Present
Attending Physician, Department of Medicine
Long Island Jewish Medical Center, New Hyde Park, NY
February 2002 – Present
Attending Physician, Department of Medicine
North Shore University Hospital, Manhasset , NY
February 1997 - Present
Attending Physician and Teaching Affiliate, Department of Medicine
New York Hospital Medical Center of Queens, Flushing, NY
September 1996 – Present
Attending Physician and Teaching Affiliate, Department of Medicine
North Shore University Hospital at Forest Hills, Forest Hills, NY
August 1996 – Present
Postdoctoral Training
Sub-Specialty Course Training
November 1999
Endoscopic Ultrasonography, Diagnostic and Therapeutic
Massachusetts General Hospital, Harvard Medical School, Boston, MA
Mentor William Bruges MD
Chief of gastro endoscopy And interventional research
Harvard Medical School , Boston MS
Aug 2001
Mayo Clinic Rochester MN
Endoscopic ultra sound and Interventional Therapeutic Endoscopy
Mentor Christopher Gestoute MD
August 2002
Endoscopic Ultrasonography
P Patrick Basu CV
3
Olympus Corporation, New York, NY
June 2003
Endoscopic Ultrasonography
Academic Medical Center, Amsterdam Netherlands
Mentor Paul Faulken MD
Fellowship:
1993 – 1996
Gastroenterology and Hepatology
Mount Sinai School of Medicine, New York, NY
Residency:
1992 – 1993
Senior Chief Medical Resident and Research Coordinator
New York Downtown Hospital, New York, NY
1990 – 1992
Department of Internal Medicine
Lenox Hill Hospital, New York, NY
1989—1990
Internship in Dept of medicine
Lenox hill hospital
E 76 th st and Park avenue
NY NY
1987– 1989
Bio-Research Assistant,
Harvard Medical School, Mass General Hospital
Boston, MS
Role of Amino Acids in Insulin resistance and Diabetes Type II
1984-1987
Royal Free Hospital London UK
Senior Registrar Dept of Medicine
Prof Neil Macintyre
Hepato Biliary unit
Mentor Dame Sheila Sherlock
1983 – 1984
Resident Medical Advisor – American Embassy, South East Asia ,
Medical licensing M B B S, 1983-1984
Bachelor of Medicine and Bachelor of Surgery
University of Calcutta. Calcutta India,
P Patrick Basu CV
4
1982 – 1983
Senior Resident – Department of Internal Medicine and Cardiology
Indian Postgraduate Medical Education and Research Institute
Calcutta, India
1981 – 1982
Department of Internal Medicine
IPGMER
S.S.K.M. Hospital, Calcutta, India
1980—1981
Compulsory rotatory internship dept of medicine
All Indian Post Graduate Institute
Indian Post Graduate
A J C Bose road , Calcutta India
1975—1980
All Indian institute of Post graduate and research
A J C Bose road ,Calcutta, India,
1974—1975
Pre medical Sir guru das college
Narkel Dangha road calcutta India.
Internship:
1989 – 1990
Lenox Hill Hospital, New York, NY
Honors/Awards
2010
Young Investigators Forum on Functional GI Disorders- FBG (Functional Brain Gut
Research)- Role of Melatonin In Colonic Motility in Irritable Bowel Syndrome – Constipation
A Double Blinded Randomized Placebo control clinical trial ( MIMI C ), Tuscon, Arizona
2010
Abstract No.: SA00385 ( AGD SILVER PRIZE 8,000 rmb ). A new four-day regimen with
dexlansoprazole, moxifloxacin, amoxicillin, nitazoxanide, and doxycycline (DeMAND) in
helicobacter pylori therapy: an open-label randomized clinical trial
2009
Poster of distinction at Digestive Disease Week 2009, Chicago –
―Rifaximin Salvage therapy for Metronidazole resistant Clostridium difficile Colitis”
2009
P Patrick Basu CV
5
Full Bursary award to attend the EASL Special Conference on NAFLD/NASH and Related
Metabolic Disease, taking place in Bologna, Italy, September 24-26, 2009
2009
AGD Silver Prize of RMB 8000 from The Third Ditan International Conference on Infectious
Diseases to be held at Beijing, China from 30 July - 2 Aug , 2009
2009
Presidential Plenary Oral Presentation at the American College of Gastroenterology Meeting,
San Diego, October 2009, A Randomized Open-Label Clinical Trial With Levofloxacin,
Omeprazole, Alinia (Nitazoxanide), And Doxycycline (LOAD) Versus Lansoprazole,
Amoxicillin And Clarithromycin (LAC) In The Treatment Naive Helicobacter pylori
Population
2009
ACG Auxiliary award - The best Scientific paper submitted by a member/fellow of the College,
ACG (American College of Gastroenterology) Oct 2009, A Randomized Open Label Clinical
Trial With Oral Alpha Lipoic Acid And Vitamin E In Non Alcoholic Fatty Liver Disease
2009
Presidents Award for poster – ACG (American College of Gastroenterology) Oct 2009,
Rifaximin Salvage Therapy for Metronidazole-Resistant Clostridium difficile Infection—A
Prospective Pilot Trial
2008
Presidential poster recognition at American College of Gastroenterology Meeting 2008,
Orlando –
―A Retrospective Analysis of the Safety of Outpatient Percutaneous Liver Biopsy in Patients
with Von Willebrand Disease”
1990 – 1991
Outstanding Performance in Residency
Lenox Hill Hospital, New York, NY
ACG/NIH GRANT ACCEPTED 2010
Serum Level Actin Free Gc-globulin: Prognosis of Acute Necrotizing Pancreatitis
Clinical Experience
Gastroenterology, Liver Disease & Nutrition, Internal Medicine
August 1996 – Present
Private Practice, Forest Hills, NY
August 2002 – Present
Private Practice – New York, NY
P Patrick Basu CV
6
Emergency Medicine
August 1996 – July 1998
Attending Physician, E.D.
St. Anthony’s Hospital, Warwick, NY
November 1992 – March 1997
Attending Physician, E.D.
North Shore University Hospital at Forest Hills, Forest Hills, NY
1992-1993
Attending Physician, E.D.
New York Downtown Hospital, New York, NY
1992-1993
Attending Physician, E.D.
Maimonides Medical Center, Brooklyn, NY
Patents
Endoscopic Repair Of Trachea esophageal Fistula (Tissue Graft Sealant
Method. Patent issued.
Endoscopic Placement of Gastric Balloon (EPGB) For Morbid Obesity –
Patent Issued
AUTHOR - TEXT BOOK – 5 CHAPTERS (in press)
Liver Disease and Transplantation: An Algorithmic Approach to Workup and Management of
Common Problems- 2nd
author, Columbia University College of Physicians and Surgeons, NY
Section 8 – Inherited Metabolic Liver Diseases
1. Alpha-1 antitrypsin
2. Wilsons Disease
3. Hereditary Hemachromatosis
Section 9 – Autoimmune and Cholestatic Liver Disease
1. Primary Biliary Cirrhosis
2. Primary Sclerosing Cholangitis
Research
2010
Combination therapy with Pegylated Interferon alfa 2a and Tenofovir in Chronic hepatitisB e
antigen negative naïve population- A randomized open label clinical trial
Assessment of Tissue Tumor Necrosis factor alfa (TTNF–α) as a novel marker for latent Celiac
disease
P Patrick Basu CV
7
HSP-70 as a unique clinical surrogate marker for Hypoxic Hepatopathy
Interferon alfa Antibody (INF alfa AB) as a useful predictive marker of therapy in Chronic
hepatitis C achieving SVR in naïve population
Combination of Interferons (IFa2b plus Consensus Interferons CIFN) in Treatment of Chronic
Hepatitis C - Non responders: COMIT-C Trial – Multicenter Trial
Transdermal Rivastigmine for Treatment of Encephalopathy in Liver Cirrhosis - A Randomized
Placebo Controlled Trial (TREC – trial )
Serum Level Actin Free Gc-globulin: Prognosis of Acute Necrotizing Pancreatitis
Tissue Eotaxin is a precise maker for eosinophilic esophagitis: A double blind RCT trial
2009
A Randomized Open Label Clinical Trial With Pregabalin In The Treatment Regime With
Interferon Therapy For Chronic Hepatitis C
Randomized controlled trial to establish the efficacy of Sorafenib in portal hypertension: A
Multicenter clinical trial
Role of Melatonin In Colonic Motility in Irritable Bowel Syndrome – Constipation A Double
Blinded Randomized Placebo control clinical trial ( MIMI C )
Effect of High-Dose Ribavirin (RBV), Alinia (Nitazoxanide) and Pegylated Interferon (PegIFN)
alfa-2a in attaining Sustained Virologic Response (SVR) in Treatment of Chronic Hepatitis C
(ERAIS-C Trial) in Naïve Genotype 1 Patients
Effects of Sub Lingual Metochlorpropamide in optimizing out patient late elective endoscopy: A
randomized double blind, double dummy placebo control clinical trial
VANISH-C (Viral kinetics with additive effect of Nitazoxanide as Immune Modulator in activating
SVR in Hepatitis C ) study
Romoplostin for thrombocytopenia in HCV
Nitazoxanide in Irritable Bowel Syndrome
Dexlansoprozole( kapidex), Moxafloxacin, Amoxicilline, Nitazoxanide.and Doxycilline (DeMA N
D ) for four days vs Week therapy with Levofloxacin , Omeprazole Nitazoxanide,And Doxicycline
( L O A D ) in naive Helicobacter Pylori Therapy in the community: A Double Blinded
Randomized clinical Pilot study In New York
P Patrick Basu CV
8
REtrospective Analysis of Pan Asian Outcome of Response to Therapy for Hepatitis C - A
Multicenter Study. REPORT-C study – Columbia University, University of Hong Kong & PGI
Chandigarh India
Assessment of von Willebrand disease in patients with liver biopsy, a retrospective study
A Randomized Open-Label Clinical Trial With Levofloxacin, Omeprazole, Alinia (Nitazoxanide),
And Doxycycline (LOAD) Versus Lansoprazole, Amoxicillin And Clarithromycin (LAC) In The
Treatment Naive Helicobacter pylori Population
2008
LEND (Levofloxacin, Esomeprazole, Nitazoxanide and Doxycycline) for the Treatment of
Previously Non-Responsive Helicobacter Pylori
Sequential Nitazoxanide Compared to Sequential Vancomycin as a Salvage Therapy in Recurrent
CDI (Clostridium difficile Infection ) a Prospective Open-Label Randomized Clinical Trial
Rifaximin Salvage Therapy for Metronidazole-Resistant Clostridium difficile Infection—A
Prospective Pilot Trial
Efficacy and Clinical Outcome of oral Rifaximin and Nitazoxanide in IBS ( diarrheal type ). A
placebo control clinical trial
Intraepithelial CD3 and CD 4 as a unique surrogate marker for mucosal immunity in Irritable
Bowel Syndrome
A Randomized Open Label Clinical Trial With Oral Alpha Lipoic Acid And Vitamin E In Non
Alcoholic Fatty Liver Disease
A Randomized Open Label Clinical Trial with Pregabalin in the Treatment Regime with Interferon
Therapy for Chronic Hepatitis C
Prevalence of Restless Leg Syndrome in Patients With Functional Bowel Disease in the
Community
Melatonin in Refractory Gastric Acid related reflux Disease ( MR- GARD ). A randomized
Placebo control clinical trial with Melatonin & Dexlansoprazole
2007
Randomize Double-Blinded Trial with Escalated Dose of Rifaximin, Omeprazole and
Levofloxacin therapy to eradicate H-Pylori. Naïve patients
Pilot Study for the Treatment of Metronidazole Resistant C-Difficile Diarrhea.
P Patrick Basu CV
9
Randomized Double-Blinded Placebo Control Trial: Alum (Aluminum, Magnesium Tricylicate)
Enema for Radiation Proctopathy
2005
EDIT-C (Escalated Dose of Interferon Therapy for Non-Responders of Chronic Hepatitis-C
Population P. Pat Basu, MD & Robert Brown Jr, MD
New York Hospital Queens and New York Presbyterian Medical Center
A Head-to-head trail between Adefovirdipovixil, 10mg used once a day vs. Entacavir .0.5mg once
a day for forty-eight (48) weeks for eantigen negative naïve chronic Hepatitis-B patients.
P. Pat Basu, MD & Natalie Baker, MD
New York Hospital Queens
A precise prognostic index for Acute Pancreastitis (P.A.N.C.R.E.A.S.)
P. Pat Basu, MD
A Pilot study with novel triple therapy to eradicate H-Pylori. Naïve patients with Rifaximin,
Omeprazole and Levofloxain
P. Pat Basu, MD & Frank Palumbo, MD
New York Hospital Queens
2004
TRAGEIC Score, an accurate prognostic clinical index of Acute Liver Failure
P. Pat Basu, MD & Robert Brown Jr, MD
New York Hospital Queens and New York Presbyterian Medical Center
Novel pilot study to eradicate H-pylori naive patient with Rifaximin, Omeprazole and Bismuth
2002
A Randomized Double Blind Trial To Evaluate The Effect and Efficacy Of Esmoprazole over
Lansoprazole On A Continuos 48 Hour pH Monitor With Acid Provoking Meals.
Academic Grant from Astra Zeneca – New York Hospital of Queens
Double Blinded Placebo Controlled Trial ―Anti Fibrotic Effect Of Lecithin-Choline On Non-
Alcoholic Fatty Liver Disease (NAFLD)‖
With Robert Brown, Jr. MD - New York-Presbyterian, New York, NY
1993-1996
―Randomized Multicenter Placebo Control Double Blinded Clinical Trial in Controlling the
Progression of Cirrhosis with Polyenylphosphatidylcholine (P.P.C.).‖
V.A. Medical Center, Bronx, NY
1994 – 1995
Carbohydrate Deficient Transferin (C.D.T.) As An Index Marker For Alcohol Relapse.
P Patrick Basu CV
10
V.A. Medical Center, Bronx, NY
1993 – 1994
―Role of Tissue Inhibitor of Metallopsotrinase (T.I.M.P.) in Abstinent Alcoholics as a Surrogate
Index of Fibrosis.‖
V.A. Medical Center, Bronx, NY
1987 – 1989
Research Role of ―Animo Acids in Hyperlipidemia‖
Ingeborg Laboratories, Merrick, NY
Papers in Preparation
Randomized, Placebo-Controlled Trial of Transdermal Rivastigmine for the Treatment of
Encephalopathy
Effect of Melatonin on Colonic Motility in Patients with Irritable Bowel Syndrome with
Constipation (MIMI-C Trial)
Hepatits C Virus: Clnical Features and Recommendations for Screening, Diagnosis and
Treatment
A Randomized Open-Label Clinical Trial Comparing a Novel Four Drug Regimen LOAD
(Levofloxacin, Omeprazole, Nitazoxinide and Doxycycline) versus LAC (Lansoprazole,
Amoxicillin and Clarithromycin) for the Eradication of Helicobacter pylori
A Randomized Open-Label Trial of Pregablin for the Reduction of Interferon-Induced Adverse
Events in Patients with Chronic Hepatits C Virus.
Effects of Triple Drug Therapy with Nitazoxinide, High-Dose Ribavirin, and Pegylated
Interferon α2a in Patients with Chronic Hepatits C.
Basu, P Patrick; Rayapudi, Krishna; HABIT (H-Homocysteine, A-ALT, B-BMI, I-Insulin
resistance, T-TNF-alpha) score to evaluate severity of Non-Alcoholic Steato Hepatitis
Basu, P Patrick; Rayapudi, Krishna; Kandanati, Vivek; Puran, Ram; Human Heart -Fatty Acid
Binding Protein as an Early Serum Marker for Myocardial Injury, submitted to IRB at Long
Island Jewish Health System
Basu, P Patrick; Rayapudi, Krishna ; Tommy Pacana; Robert Brown Jr; Erectile dysfunction in
NASH patients
Basu, P Patrick; Rayapudi, Krishna ; Tommy Pacana; Robert Brown Jr IL6 levels as a predictor
of SVR in HCV therapy
Basu, P Patrick; Robert Brown Jr ; Rayapudi, Krishna ; Tommy Pacana; Romiplostim for
treatment of Hepatitis C associated thrombocytopenia
Basu, P Patrick; Rayapudi, Krishna ; Brown Jr, Robert; Liver Fatty Acid Binding Protein as a
predictor of reperfusion injury in post Liver transplant patients- being written up for NIH grant
Basu, P Patrick, Rayapudi, Krishna; A Randomized placebo controlled prospective study with
Mesalamine Suppository to control diarrheal symptoms in IBS
Basu, P Patrick, Rayapudi, Krishna; A Randomized trial comparing Baclofen enema with
Glycerin enema in Mast Cell Proctopathy of Irritable Bowel Syndrome
P Patrick Basu CV
11
P Patrick Basu MD, K Rayapudi MD, Tommy Pacana MD, Robert S. Brown Jr; Gc protein in
Pancreatitis
P Patrick Basu MD, K Rayapudi MD, Tommy Pacana MD, Rotigotin in Patients with Restless
Leg Syndrome
Case series on portal biliopathy
Case report on Pancreatic pseudocyst extending into the pericardium
Case report on Fish bone extraction from duodenal mucosa
Publications Prevalence of Restless Legs Syndrome in Patients with Irritable Bowl Syndrome. World
Journal of Gastroentrology. In Press
Entecavir for Treatment of Decompensated Chronic Hepatitis B: A Clinical Update. Expert
Review of Gastroenterology & Hepatology
Therapeutic Advances in Gastroenterology July 2010 vol. 3 no. 4 221-225., Rifaximin therapy
for metronidazole-unresponsive Clostridium difficile infection: a prospective pilot trial
Gastroenterology and Hepatology, Volume 5, Issue 11, November 2009, Page 801, A
Randomized Open-Label Clinical Trial With Levofloxacin, Omeprazole, Alinia
(Nitazoxanide), And Doxycycline (LOAD) Versus Lansoprazole, Amoxicillin And
Clarithromycin (LAC) In The Treatment Naive Helicobacter pylori Population
―Chlorzoxazone Pharmacokinetics as a Marker of Hepatic Cytochrome P4502E1 in Humans‖
Mt. Sinai School of Medicine and V.A. Medical Center, NY;The American Journal of
Gastroenterology, Vol. 93, No. 11, 1998
―Utility of Carbohydrate-Deficient Transferrin as a Marker of Relapse in Alcoholic Patients‖
Alcohol Clinical and Experimental Research, Vol. 19, No3, 1995: pp 611-616
―Efficacy of a High and Accelerated Dose of Hepatitis B Vaccine in Alcoholic Patients, a
Randomized Clinical
Trial‖;American Journal of Medicine September 1997, Volume 103
―Effectiveness of High Dose Hepatitis B Vaccine in Alcoholic Patients, a Randomized Placebo
Controlled Trial‖
Published as an abstract in Gastroenterology, 1995;108:a1158
―Case Report in Factitious Diarrhea from Ingestion of Aloe‖; Journal of North Shore
University Hospital of Forest Hills, 1996
―Intractable Hiccups from Colonic Intersussuption‖, 1996
Published Abstracts/Poster
P.Patrick Basu, MD, MRCP, Nithya Krishnaswamy, MD, Niraj James Shah, MD, Tamer
Montaser, MD, Chris Tang, MD,PhD and Robert Brown, MD Pan-Asian Variability of
Interleukin 28B (IL28B) Gene Polymorphism and Relationship to Sustained Viral Response
P Patrick Basu CV
12
(SVR) in Chronic Hepatitis C Genotype 1; A Retrospective Study - PANIC TRIAL. June
2011, ILTS. In Press
P.Patrick Basu, MD, MRCP, Nithya Krishnaswamy, MD, Niraj James Shah, MD, Tamer
Montaser, MD, Chris Tang, MD, PhD and Robert Brown, MD Transdermal Rivastigmine for
Treatment of Encephalopathy in Liver Cirrhosis - A Randomized Placebo Controlled Trial
(TREC trial ). June 2011, ILTS. In Press-
P Patrick Basu, N V Krishnaswamy, N James Shah, S Farhat, R S Brown "Serum Retinol
Binding Protein 4 (RBP-4) is a unique surrogate marker of End stage Liver Disease. June, 2011
EASL Monothematic Conference- Liver Fibrogenesis. In Press
P Patrick Basu, Niraj James Shah, Nithya Krishnaswamy, Chris Tang. EFFECT OF
MELATONIN IN FUNCTIONAL HEART BURN--A RANDOMIZED PLACEBO-
CONTROLLED CLINICAL TRIAL. Sept, 2011, Neurogastroentrology & Motility. In Press
P Patrick Basu, Niraj James Shah, Nithya Krishnaswamy, Chris Tang. Effect of Melatonin in
Functional Heart Burn- A Randomized Placebo-Controlled Clinical Trial. Gastroenterology
May 2011, Vol. 140, Issue 5, Supplement 1, Page S-169
P Patrick Basu, Niraj James Shah, Nithya Krishnaswamy, Chris Tang. Comparison of
Nitazoxanide and Vancomycin Taper Regimens as a Salvage Therapy for Patients With
Recurrent Mild to Moderate Clostridium difficile Infection (CDI). Gastroenterology May 2011,
Issue 5, Supplement 1, Page S-325
Patrick Basu, Nithya Krishnaswamy, Niraj James Shah, Chris Tang Serum Retinol Binding
Protein 4 (RBP-4) is a Unique Surrogate Marker of END Stage Liver Disease With
Complications. A Pilot Clinical Trial. Gastroenterology May 2011, Vol. 140, Issue 5,
Supplement 1, Page S-957.
P Patrick Basu, Nithya Krishnaswamy, Niraj James Shah, Sajith J. Foustin, Chris Tang, Robert
S. Brown. Interferon Alfa Antibody (IFN Alfa Ab) as a Useful Predictive Marker of Sustained
Viral Response (SVR) for Therapy in Chronic Hepatitis C. Gastroenterology May 2011, Issue
5, Supplement 1, Page S-911
P Patrick Basu, Niraj James Shah, Nithya Krishnaswamy, Robert S. Brown. Effects of
Interferon Alpha on Parathyroid Gland in Chronic Hepatitis B and C: An Observational Study.
Gastroenterology May 2011, Issue 5, Supplement 1, Page S-970
P Patrick Basu, Niraj James Shah, Nithya Krishnaswamy, Sajith J. Foustin, Chris Tang, Tommy
Pacana, Robert S. Brown
. Pan-Asian Variability of Interleukin 28b (IL28B) Gene
Polymorphism and Relationship to Sustained Viral Response (SVR) in Chronic Hepatitis C
Genotype 1. Gastroenterology May 2011, Issue 5, Supplement 1, Pages S-455-S-456.
P Patrick Basu, Hemanth Hampole, Niraj James Shah, Vinod Mohan, Nithya Krishnaswamy,
P Patrick Basu CV
13
Chris Tang, Tamer Montaser. Effects of Orally Disintegrated Metoclopramide (ODM) in
Optimizing Late Out Patient Endoscopy: A Randomized Double-Blinded Placebo Control
Clinical Trial. Gastrointestinal Endoscopy April 2011, Vol. 73, Issue 4, Supplement, Page
AB40
P Patrick Basu, MD,MRCP, AGAF, N James Shah MD, N V Krishnaswamy MD, Tommy
Pacana MD, J Khemani MD, S Farhat MD, C Tang MD, PhD R S Brown Jr MD .MPH; . Effect
of Vitamin E and Alfa Lipoic Acid In Non-alcoholic fatty liver disease: A randomize placebo
control prospective clinical Trial-V A I N Trial. Journal of Diabetes. 2011 April; Volume 3,
(Supplements1)Pages iv–iv, 11
P.P. Basu, N. Krishnaswamy, N.J. Shah, T. Pacana, C. Tang, S. Foulstin, R.J. Brown. Serum
Retinol Binding Protein 4 as a unique surrogate marker of End stage Liver Disease with
Complications. A Pilot trial. Heptaology International. February 2011, Volume 5, Number 1
P.P. Basu, N.J. Shah, N. Krishnaswamy, S. Foustin, C. Tang, T. Pacana, R.J. Brown. Pan-
Asian Variability of Interleukin 28B (IL28B) Gene Polymorphism and Relationship to
Sustained Viral Response (SVR) in Chronic Hepatitis C. Heptaology International. February
2011, Volume 5, Number 1
P.P. Basu, N. Krishnaswamy, N.J. Shah, T. Pacana, S. Foulstin, C. Tang, R.J. Brown.
Effects
of Interferon Alpha on Parathyroid Gland in Chronic Hepatitis B and C: An Observational
Study. Heptaology International. 2011, Volume 5, Number 1
P.P. Basu, N.J. Shah, N. Krishnaswamy, S. Foustin, C. Tang, T. Pacana, R.J. Brown. Interferon
alfa Antibody A Useful Predictive Marker of Sustained Viral Response (SVR) for Therapy in
Chronic Hepatitis C. Heptaology International. 2011, Volume 5, Number 1
P Patrick Basu, MD,MRCP, AGAF, N James Shah MD, N V Krishnaswamy MD,
Tommy Pacana MD, J Khemani MD, S Farhat MD, C Tang MD, PhD R S Brown Jr MD
.MPH; . Effect of Vitamin E and Alfa Lipoic Acid In Non-alcoholic fatty liver disease: A
randomize placebo control prospective clinical Trial-V A I N Trial. 4th International Congress
on Prediabetes and the Metabolic Syndrome in Madrid, Spain, April 6-9, 2011
The 21st Conference of the Asian Pacific Association for the Study of the Liver
(APASL 2011)17-20 February 2011, QSNCC, Bangkok Thailand. Serum Retinol Binding
Protein 4 as a unique surrogate marker of End stage Liver Disease with Complications. A Pilot
trial
The 21st Conference of the Asian Pacific Association for the Study of the Liver
(APASL 2011)17-20 February 2011, QSNCC, Bangkok Thailand. Pan-Asian Variability of
Interleukin 28B (IL28B) Gene Polymorphism and Relationship to Sustained Viral Response
(SVR) in Chronic Hepatitis C
The 21st Conference of the Asian Pacific Association for the Study of the Liver
(APASL 2011)17-20 February 2011, QSNCC, Bangkok Thailand. Effects of Interferon Alpha
on Parathyroid Gland in Chronic Hepatitis B and C: An Observational Study
The 21st Conference of the Asian Pacific Association for the Study of the Liver
(APASL 2011)17-20 February 2011, QSNCC, Bangkok Thailand. Interferon alfa Antibody
A Useful Predictive Marker of Sustained Viral Response (SVR) for Therapy in Chronic
Hepatitis C
A New Four-day regimen with Dexlansoprazole, Moxifloxacin, Amoxicillin, Nitazoxanide,
and Doxycycline (DeMAND) in Helicobacter Pylori Therapy: An Open-label Randomized
Clinical Trial. American Journal of Gastroentrology. ACG 2010, San Antonio, TX; October
18-20
P Patrick Basu CV
14
Sequential Use of Nitazoxanide(NTZ) as a Salvage Therapy in Patient with Recurrent Mild to
Moderate Clostridium Difficile Infection (CDI): A Prospective, Open–label, Randomized
Clinical Trial ACG 2010, San Antonio, TX; October 18-20
Effects of Orally Disintegrated Metoclopramide (ODM) in Optimizing Late Outpatient
Endoscopy: A Randomized Double-Blind Placebo-Controlled Clinical Trial ACG 2010, San
Antonio, TX; October 18-20
Effect of Melatonin in Functional Heart Burn- A Randomized Placebo Control Clinical Trial.
ACG 2010, San Antonio, TX; October 18-20
Interferon alfa Antibody (IFN alfa Ab) As A Useful Predictive Marker of Sustained Viral
Response (SVR) for Therapy in Chronic Hepatitis C
Hepatology International. 2010 Mar; 4(1): 201, Effect of High-Dose Ribavirin (RBV),
Alinia (Nitazoxanide) and Pegylated Interferon (PegIFN) alfa-2a in attaining Sustained
Virologic Response (SVR) in Treatment of Chronic Hepatitis C (ERAIS-C Trial) in Naïve
Genotype 1 Patients
Hepatology International. 2010 Mar; 4(1): 172, REtrospective Analysis of Pan
Asian Outcome of Response to Therapy for Hepatitis C - A Multicenter Study. REPORT-C
study – Columbia University, University of Hong Kong & PGI Chandigarh India,
Hepatology International. 2010 Mar; 4(1): 37, Transdermal Rivastigmine for Treatment
of Encephalopathy in Liver Cirrhosis - A Randomized Placebo Controlled Trial (TREC – trial)
Neurogastroenterology and Motility 2010. 2010 Aug; 22(S1, 23-90) 67, Role of
Melatonin In Colonic Motility in Irritable Bowel Syndrome – Constipation A Double blinded
randomized Placebo control clinical trial ( MIMI C )
Basu, K. Rayapudi, N.J. Shah, T. Pacana, N. Krishnaswamy, R. Brown Jr.. Effect of
High-dose Ribavirin (RBV), Alinia(Nitazoxanide)and Pegylated Interferon (PegIFN) ALFA-
2A in attaining Sustained Virologic Response (SVR) in Treatment of Chronic Hepatitis C
(ERAIS-C) in naive genotype 1 patients. Journal of Hepatology. 2010 Apr; 52(1): S102.
P. Basu, N.J. Shah, N. Krishnaswamy, H. Hampole, T. Pacana, K. Rayapudi, R. Brown
Jr.. Transdermal Rivastigmine for Treatment of Encephalopathy in Liver Cirrhosis. A
Randomized Placebo Controlled Trial (TREC Trial). Journal of Hepatology. 2010 Apr; 52(1):
S67-S68.
P. Patrick Basu, Krishna Rayapudi, Tommy Pacana, Niraj James Shah, Nithya
Krishnaswamy, Chris Tang, Robert Brown Effect of high-dose ribavirin (RBV), alinia
(Nitazoxanide) and pegylated interferon (PegIFN) alfa-2a in attaining sustained virologic
response (SVR) in treatment of chronic hepatitis C (ERAIS-C Trial) in naïve genotype 1
patients. Accepted at DICID July 2010, Beijing, China, Published International Journal of
Infectious Diseases. 2010 Jul; 14(2): S1-S2.
P Patrick Basu, N James Shah, N V Krishnaswamy, R Korapati, and CC Tang Sequential use
of nitazoxanide (NTZ) as a salvage therapy in patient with recurrent mild to moderate
clostridium difficile infection (CDI): A prospective, open–label, randomized clinical trial.
Accepted at DICID July 2010, Beijing, China, Published International Journal of Infectious
Diseases.
P Patrick Basu, MD, N.V Krishnaswamy MD, R Korapati, MD, S Tammisetti MD, N James
Shah MD, H Hampole MD, Tommy Paccana MD, CC Tang MD. PhD. A new four-day
regimen with dexlansoprazole, moxifloxacin, amoxicillin, nitazoxanide, and doxycycline
(DeMAND) in helicobacter pylori therapy: an open-label randomized clinical trial. Accepted at
P Patrick Basu CV
15
DICID July 2010, Beijing, China, Published International Journal of Infectious Diseases 2010
Jul; 14(Supplement 2): S52.
Patrick Basu, Krishna Rayapudi, Tommy Pacana, Niraj James Shah, Robert Brown Effect of
High-Dose Ribavirin (RBV), Alinia (Nitazoxanide) and Pegylated Interferon (PegIFN) alfa-2a
in attaining Sustained Virologic Response (SVR) in Treatment of Chronic Hepatitis C (ERAIS-
C Trial) in Naïve Genotype 1 Patients, APASL 2010, Beijing, March 2010
P Patrick Basu, Krishna Rayapudi, Tommy Pacana, Niraj James Shah, Robert Brown
REtrospective Analysis of Pan Asian Outcome of Response to Therapy for Hepatitis C - A
Multicenter Study. REPORT-C study – Columbia University, University of Hong Kong & PGI
Chandigarh India. APASL 2010, Beijing, March 2010
P Patrick Basu, Krishna Rayapudi, Tommy Pacana, Niraj James Shah, Robert Brown
Transdermal Rivastigmine for Treatment of Encephalopathy in Liver Cirrhosis - A
Randomized Placebo Controlled Trial (TREC – trial ) , APASL 2010, Beijing, March 2010
P Patrick Basu, Krishna Rayapudi, Tommy Pacana, Niraj James Shah, Robert Brown Effect of
High-Dose Ribavirin (RBV), Alinia (Nitazoxanide) and Pegylated Interferon (PegIFN) alfa-2a
in attaining Sustained Virologic Response (SVR) in Treatment of Chronic Hepatitis C (ERAIS-
C Trial) in Naïve Genotype 1 Patients, EASL 2010
P Patrick Basu, Krishna Rayapudi, Tommy Pacana, Niraj James Shah, Robert Brown
Transdermal Rivastigmine for Treatment of Encephalopathy in Liver Cirrhosis - A
Randomized Placebo Controlled Trial (TREC – trial ) , EASL 2010
Gastroenterology Vol. 138, Issue 5, Supplement 1 , Page S-218, Effect of High-Dose Ribavirin
(RBV), Alinia (Nitazoxanide) and Pegylated Interferon (PegIFN) alfa-2a in attaining Sustained
Virologic Response (SVR) in Treatment of Chronic Hepatitis C (ERAIS-C Trial) in Naïve
Genotype 1 Patients,
Gastroenterology Vol. 138, Issue 5, Supplement 1 , Page S-368, Transdermal Rivastigmine
for Treatment of Encephalopathy in Liver Cirrhosis - A Randomized Placebo Controlled Trial
(TREC – trial ),
Gastroenterology Vol. 138, Issue 5, Supplement 1 , Page S-305, Assessment of Tissue Tumor
Necrosis factor alfa (TTNF–α) as a novel marker for latent Celiac disease,
Gastroenterology Vol. 138, Issue 5, Supplement 1 , Pages S-625-S-626, Intraepithelial CD3
and CD 4 as a unique surrogate marker for mucosal immunity in Irritable Bowel Syndrome
17TH
International meeting on hepatitis C and related virus, September 2010, page 148,
Abstract ID: 20401: Effect of High-Dose Ribavirin (RBV), Alinia (Nitazoxanide) and
Pegylated Interferon (PegIFN) alfa-2a in attaining Sustained Virologic Response (SVR) in
Treatment of Chronic Hepatitis C (ERAIS-C Trial) in Naive Genotype 1 Patients
17TH
International meeting on hepatitis C and related virus, September 2010, page 150,
Abstract ID: 20405: A Randomized Open Label Clinical Trial With Pregabalin in the
Treatment Regime With Interferon Therapy for Chronic Hepatitis C
17TH
International meeting on hepatitis C and related virus, September 2010, page 147,
Abstract ID: 20400: Interferon alfa Antibody (IFN alfa Ab) As A Useful Predictive Marker of
Sustained Viral Response (SVR) for Therapy in Chronic Hepatitis C
17TH
International meeting on hepatitis C and related virus, September 2010, page 154,
Abstract ID: 20404: A Retrospective Analysis of the Safety of Outpatient Percutaneous Liver
Biopsy in Patients with Von Willebrand Disease
P Patrick Basu CV
16
17TH
International meeting on hepatitis C and related virus, September 2010, page 155,
Abstract ID: 20406: Serum Retinol Binding Protein 4 (RBP-4) is a unique surrogate marker of
End stage Liver Disease with Complications. A Pilot clinical trial.
17TH
International meeting on hepatitis C and related virus, September 2010, page 149,
Abstract ID: 20402: Retrospective Analysis of Pan Asian Outcome of Response to Therapy for
Hepatitis C - A Multicenter Study (REPORT-C study)
Encephalopathy in Chronic Liver Failure, poster presentation done at EASL Monothematic
Conference on Portal Hypertension, Budapest, Hungary, January 2009
P Patrick Basu, Krishna Rayapudi, Jose Esteves, Robert Brown; A Retrospective Analysis of
the Safety of Outpatient Percutaneous Liver Biopsy in Patients with Von Willebrand Disease,
poster presentation done at EASL Monothematic Conference on Portal Hypertension,
Budapest, Hungary, January 2009
P Patrick Basu, Krishna Rayapudi, Tommy Pacana, Syed Hussein, Sindhu Ramamurthy,
Robert Brown Jr; A Randomized Open Label Clinical Trial With Pregabalin in the Treatment
Regime with Interferon Therapy For Chronic Hepatitis C, accepted for poster presentation at
19th
APASL Conference, Hong Kong, February 2009
P Patrick Basu, Krishna Rayapudi, Tommy Pacana, Syed Hussein, Sindhu Ramamurthy,
Robert Brown Jr; A Randomized Open Label Clinical trial with Oral Alfa Lipoic Acid and
Vitamin E in Non Alcoholic Fatty Liver disease, accepted for poster presentation at 3rd
International Congress on Prediabetes and the Metabolic Syndrome, Nice, France, April 2009
P Patrick Basu; Krishna Rayapudi; Tommy Pacana; Syed Hussein; Sindhu Ramamurthy;
Robert brown Jr; A Randomized Open label clinical trial with Pregabalin in the Treatment
Regimen with Interferon Alfa for Chronic Hepatitis C – accepted for poster presentation at
Asia Pacific Association for Study of Liver Disease Meeting , Hong Kong 13-16th
February
2009 and at the 13th
International Symposium on Viral hepatitis and Liver Disease,
Washington DC, March 20-24, 2009.
P Patrick Basu; Krishna Rayapudi; Tommy Pacana; Syed Hussein; Sindhu Ramamurthy;
Robert brown Jr; A Randomized Open label clinical trial with Pregabalin in the Treatment
Regimen with Interferon Alfa for Chronic Hepatitis C – accepted at Asia Pacific Association
for Study of Liver Disease Meeting , Hong Kong 13-16th
February 2009 and at the 13th
International Symposium on Viral hepatitis and Liver Disease, Washington DC, March 20-24,
2009
P Patrick Basu; Krishna Rayapudi; Tommy Pacana; Sindhu Ramamurthy; Robert brown Jr; A
randomized open label clinical trial with Alpha Lipoic acid and Vitamin E in Non-alcoholic
fatty liver disease – accepted at Asia Pacific Association for Study of Liver Disease Meeting ,
Hong Kong February 13-16, 2009 and at Digestive Disease Week 2009, Chicago
Basu, P Patrick; Dinani, Amreen; Rayapudi, Krishna; Pacana, Tommy; Ramamurthy, Sindhu;
Rifaximin Salvage therapy for Metronidazole resistant Clostridium difficile Colitis - A
Prospective Pilot Trial – Accepted at Digestive Disease Week 2009, Chicago
Basu, P Patrick; Rayapudi, Krishna; Pacana, Tommy; Ramamurthy, Sindhu; Prevalence of
Restless Leg Syndrome in patients with functional bowel disease in the community - accepted
as a poster presentation at the 2009 Neurogastroenterology and Motility Joint International
meeting to be held August 27-30, 2009 in Chicago, Illinois
P Patrick Basu; Krishna Rayapudi; Tommy Pacana; Sindhu Ramamurthy; Robert brown Jr; A
randomized open label clinical trial with Alpha Lipoic acid and Vitamin E in Non-alcoholic
fatty liver disease - selected for poster presentation at the EASL Special Conference on
P Patrick Basu CV
17
NAFLD/NASH and Related Metabolic Disease, taking place in Bologna, Italy, September 24-
26, 2009
Basu, P Patrick; Dinani, Amreen; Rayapudi, Krishna; Pacana, Tommy; Ramamurthy, Sindhu;
Rifaximin Salvage therapy for Metronidazole resistant Clostridium difficile Colitis - A
Prospective Pilot Trial –Accepted for poster presentation at the Third Ditan International
Conference on Infectious Diseases to be held at Beijing, China from 30 July - 2 Aug , 2009
P Patrick Basu, Krishna Rayapudi, Vincent W. Wong, Kenneth Yan, Niraj James Shah,
Tommy Pacana, Robert S. Brown; Retrospective Analysis of Pan Asian Outcome of Response
to Therapy for Hepatitis C - A Multicenter Study- REPORT-C study – accepted for poster
presentation at AASLD 2009, Boston, MA
Basu, P Patrick; Dinani, Amreen; Rayapudi, Krishna; Pacana, Tommy; Ramamurthy, Sindhu;
Rifaximin Salvage therapy for Metronidazole resistant Clostridium difficile Colitis - A
Prospective Pilot Trial – Accepted for poster presentation at The American College of
Gastroenterology Meeting, San Diego, CA to be held from 23-28 October 2009
P Patrick Basu, Krishna Rayapudi, Vincent Wong, Kenneth Yan, Tommy Pacana, Niraj James
Shah, Robert Brown; Retrospective Analysis of Pan Asian Outcome of Response to Therapy
for Hepatitis C - A Multicenter Study (REPORT-C study) – Interim Results- Accepted for
poster presentation at The American College of Gastroenterology Meeting, San Diego, CA to
be held from 23-28 October 2009
P Patrick Basu, Krishna Rayapudi, Tommy Pacana, Niraj James Shah, Robert Brown; Effects
of High Dose Ribavirin, Alinia (Nitazoxanide) and Pegylated Interferon alfa-2a in Attaining
Sustained Viral Response in Treatment of Chronic Hepatitis C (ERAIS-C trial) - Interim
Results in Naïve Genotype 1 Patients- Accepted for poster presentation at The American
College of Gastroenterology Meeting, San Diego, CA to be held from 23-28 October 2009
P Patrick Basu, Krishna Rayapudi, Tommy Pacana, Niraj James Shah; Prevalence of Restless
Leg Syndrome in Patients With Functional Bowel Disease in the Community- Accepted for
poster presentation at The American College of Gastroenterology Meeting, San Diego, CA to
be held from 23-28 October 2009
P Patrick Basu, Niraj James Shah, Krishna Rayapudi, Tommy Pacana, Naveen P.
Narayankutty, Sherry Taylor; Intraepithelial CD3+ and CD4+ Cells as Unique Surrogate
Markers for Mucosal Immunity in Irritable Bowel Syndrome- Accepted for poster presentation
at The American College of Gastroenterology Meeting, San Diego, CA to be held from 23-28
October 2009
P Patrick Basu, Krishna Rayapudi, Tommy Pacana, Syed Hussain, Niraj James Shah, Robert
Brown; A Randomized Open Label Clinical Trial With Pregabalin In The Treatment Regime
With Interferon Therapy For Chronic Hepatitis C - Accepted for poster presentation at The
American College of Gastroenterology Meeting, San Diego, CA to be held from 23-28 October
2009
Basu, P Patrick; Rayapudi, Krishna; Estevez, Jose; A Randomized Double Blinded Clinical
Trial with Omeprazole, Levofloxacin and Escalated Dose of Rifaximin for Helicobacter Pylori
in Treatment-Naïve Population, Gastroenterology, April 2008;134, No. 4, Suppl. 1:A-336,
presented as poster at Digestive Disease Week Meeting 2008, San Diego, California
Basu, P Patrick; Rayapudi, Krishna; Robert Brown Jr MD; A Retrospective Analysis of the
Safety of Outpatient Percutaneous Liver Biopsies with Von Willebrand Disease, Hepatology
International, June 2008; 2, Suppl. 2:S131-132, presented as poster at International Liver
Congress Meeting 2008, Hong Kong, China
P Patrick Basu CV
18
PP Basu, K Rayapudi, J Esteves, R Brown Jr; A Pilot Study Utilizing Nitazoxanide for Hepatic
Encephalopathy in Chronic Liver Failure, Journal of Gastroenterology and Hepatology 2008;
23, Suppl. 5: A 49, presented as poster at Asia Pacific Digestive Week Meeting 2008, New
Delhi, India
PP Basu, K Rayapudi, R Brown Jr ; A Retrospective Analysis of the Safety of Outpatient
Percutaneous Liver Biopsies with Von Willebrand Disease, Journal of Gastroenterology and
Hepatology, September 2008; 23, Suppl. 5: A 49, presented as poster at Asia Pacific Digestive
Week Meeting 2008, New Delhi, India
PP Basu, K Rayapudi, J Esteves; LEND (Levaquin, Esomeprazole, Nitazoxanide and
Doxycycline) for the treatment of previously Non-Responsive Helicobacter pylori, Journal of
Gastroenterology and Hepatology, September 2008; 23, Suppl. 5: A 119, presented as poster at
Asia Pacific Digestive Week Meeting 2008, New Delhi, India
PP Basu, K Rayapudi, J Esteves; A Randomized Double Blinded Clinical Trial with
Omeprazole, Levofloxacin and Escalated Dose of Rifaximin for Helicobacter Pylori in
Treatment-Naïve Population, Journal of Gastroenterology and Hepatology, September 2008;
23, Suppl. 5: A 119, presented as poster at Asia Pacific Digestive Week Meeting 2008, New
Delhi, India
P Basu, K Rayapudi, J Esteves, T Crook; Mucosal Mastocytosis as a Histological Marker in
Diarrhea Predominant Irritable Bowel Syndrome, Journal of Gastroenterology and Hepatology
2008; 23, Suppl. 5: A 11
P Patrick Basu, Krishna Rayapudi, Jose Esteves; LEND (Levofloxacin, Esomeprazole,
Nitazoxanide and
Doxycycline) for the Treatment of previously Non-Responsive Helicobacter pylori, The
American Journal of Gastroenterology September 2008; 103, S1: pages S52-53 ; poster
presentation done at American College of Gastroenterology Meeting 2008, Orlando, Florida
P Patrick Basu, Krishna Rayapudi, Jose Esteves, Robert Brown; A Retrospective Analysis of
the Safety of Outpatient Percutaneous Liver Biopsy in Patients with Von Willebrand Disease,
The American Journal of Gastroenterology September 2008; 103, S1: page S164-165 ; poster
presentation done at American College of Gastroenterology Meeting 2008, Orlando, Florida
P Patrick Basu, Krishna Rayapudi, Jose Esteves, Terri Crook; Mucosal Mastocytosis as a
Histological Marker in Diarrhea Predominant Irritable Bowel Syndrome, The American
Journal of Gastroenterology September 2008; 103, S1: page S474; poster presentation done at
American College of Gastroenterology Meeting 2008, Orlando, Florida
P Patrick Basu, Krishna Rayapudi, Jose Esteves, Robert Brown; A Pilot Study Utilizing
Nitazoxanide for Hepatic Encephalopathy in Chronic Liver Failure, The American Journal of
Gastroenterology September 2008; 103, S1: page S151; poster presentation done at American
College of Gastroenterology Meeting 2008, Orlando, Florida
P Patrick Basu, Krishna Rayapudi, Jose Esteves; Novel Therapy for the Non-responder
population with H pylori - LEND (Levofloxacin, Esomeprazole, Nitazoxanide and
Doxycycline) Study; Gut October 2008; 57, Supplement 2: page A328; poster presentation
done at United European Gastroenterology Week October 2008, Vienna, Austria
P Patrick Basu, Krishna Rayapudi, Jose Esteves, Robert Brown; A Retrospective Analysis of
the Safety of Outpatient Percutaneous Liver Biopsy in Patients with Von Willebrand Disease,
Gut October 2008; 57, Supplement 2: page A387; poster presentation done at United European
Gastroenterology Week October 2008, Vienna, Austria
P Patrick Basu CV
19
Basu, P Patrick; Rayapudi, Krishna; Estevez, Jose; A Randomized Double Blinded Clinical
Trial with Omeprazole, Levofloxacin and Escalated Dose of Rifaximin for Helicobacter Pylori
in Treatment-Naïve Population, Gut October 2008; 57 Supplement 2: page A 328; poster
presentation done at United European Gastroenterology Week October 2008, Vienna, Austria
P Patrick Basu, Krishna Rayapudi, Jose Esteves, Robert Brown; A Pilot Study Utilizing
Nitazoxanide for Hepatic Encephalopathy in Chronic Liver Failure, Gut October 2008; 57
Supplement 2: page A 21
P Patrick Basu, Krishna Rayapudi, Jose Esteves, Robert Brown; A Pilot Study Utilizing
Nitazoxanide for Hepatic Encephalopathy in Chronic Liver Failure, Hepatology October
2008;48 Number4: pages 1085A-1086A; poster presentation done at American association for
the Study of Liver Disease Meeting, October-November 2008, SanFrancisco, California
P Patrick Basu, Krishna Rayapudi, Jose Esteves, Terri Crook; Mucosal Mastocytosis as a
Histological Marker in Diarrhea Predominant Irritable Bowel Syndrome,
Neurogastroenterology and Motility, November 2008; 20 supplement 2: page 69; poster
presentation done at Neurogastroenetrology and Motility Joint International Meeting,
November 2008 Lucerne, Switzerland
P Patrick Basu, Krishna Rayapudi, Jose Esteves, Robert Brown; A Pilot Study Utilizing
Nitazoxanide for Hepatic
―Argon Plasma Coagulation with 1% Alum Irrigation Reduces Re-bleeding
Associated with Radiation Proctitis―;Kaumudi Somnay, Ellen Gutkin, Ratesh Khillan, P.
Patrick Basu, Natalya Belova, Raj Wadgaonkar, Dattatreyudu Nori; accepted for DDW May
2008, San Diego, California
―A Novel Therapy With Rifixamine, Omeprazole & Levofloxacine for H pylori
Therapy in Naive Patients‖; American College of Gastroenterology, Las Vegas, NV , 10/2006
―Argon Plasma Coagulation with 1% Alum Irrigation Reduces Re-bleeding
Associated with Radiation Proctitis―; Kaumudi Somnay, Ellen Gutkin, Ratesh Khillan, P.
Patrick Basu, Natalya Belova, Raj Wadgaonkar, Dattatreyudu Nori; accepted for DDW May
2008, San Diego, California
Index and Reviews – Hepatitis – March 2004
―Giant Cell Hepatitis With Super Imposed Autoimmune Hepatitis.‖; American College of
Gastroenterology, Las Vegas 2001
―Effectiveness of High Dose Hepatitis B Vaccine in Alcoholic Patients, a randomized Placebo
Controlled Trial‖; May 1995 – American Gastroenterology Assoc. (AGA), San Diego, CA
―Utility of Carbohydrate-Deficient Transferrin as a Marker of Relapse in Alcoholic Patients.
June 1994 - Annual Meeting, Research Alcohol Assoc. (RSA), Maui, Hawaii
August 1994 - Mt. Sinai Medical Center Research Day, New York, NY
Oral Presentations
Digestive Disease Week 2011May 7-10, in Chicago, Illinois, Interferon alfa Antibody
(IFN alfa Ab) As A Useful Predictive Marker of Sustained Viral Response (SVR) for Therapy
in Chronic Hepatitis C
Digestive Disease Week 2011 May 7-10, in Chicago, Illinois, Effect of Melatonin in
Functional Heart Burn- A Randomized Placebo-Controlled Clinical Trial
P Patrick Basu CV
20
4th International Congress on Prediabetes and the Metabolic Syndrome in Madrid,
Spain, April 6-9, 2011. Effect of Vitamin E and Alfa Lipoic Acid In Non-alcoholic fatty liver
disease: A randomize placebo control prospective clinical Trial-V A I N Trial
P.Patrick Basu, MD, MRCP, Nithya Krishnaswamy, MD, Niraj James Shah, MD, Tamer
Montaser, MD, Chris Tang, MD, PhD and Robert Brown, MD Transdermal Rivastigmine for
Treatment of Encephalopathy in Liver Cirrhosis - A Randomized Placebo Controlled Trial
(TREC trial ). June 2011, ILTS. In Press-
2011 Joint International Congress of ILTS (International Liver Transplantation
Society), ELITA (The European Liver and Intestine Transplant Association) , & LICAGE (The
Liver Intensive Care Group of Europe), June 22-25, 2011, in Valencia, Spain. Transdermal
Rivastigmine for Treatment of Encephalopathy in Liver Cirrhosis - A Randomized Placebo
Controlled Trial (TREC - Trial).
2010 Neurogastroenterology and Motility Joint International meeting, Chicago, Illinois ,
Role of Melatonin In Colonic Motility in Irritable Bowel Syndrome – Constipation A Double
Blinded Randomized Placebo control clinical trial (MIMI C )
DICID 2010, Beijing 2010, OL-008: Sequential use of nitazoxanide (NTZ) as a salvage
therapy in patient with recurrent mild to moderate clostridium difficile infection (CDI): A
prospective, open–label, randomized clinical trial
DICID 2010, Beijing 2010, Effect of High-Dose Ribavirin (RBV), Alinia
(Nitazoxanide) and Pegylated Interferon (PegIFN) alfa-2a in attaining Sustained Virologic
Response (SVR) in Treatment of Chronic Hepatitis C (ERAIS-C Trial) in Naive Genotype 1
Patients
P Patrick Basu, Krishna Rayapudi, Tommy Pacana, Niraj James Shah, Robert Brown
Transdermal Rivastigmine for Treatment of Encephalopathy in Liver Cirrhosis - A
Randomized Placebo Controlled Trial (TREC – trial ) , APASL 2010, Beijing, March 2010
P Patrick Basu; Krishna Rayapudi; Tommy Pacana; Sindhu Ramamurthy; Robert brown Jr; A
randomized open label clinical trial with Alpha lipoic acid and Vitamin E in Non-alcoholic
fatty liver disease – Accepted for oral presentation The American College of Gastroenterology
Meeting, San Diego, CA to be held from 23-28 October 2009.
Basu, P Patrick; Rayapudi, Krishna; Pacana, Tommy; Ramamurthy, Sindhu; A Randomized
Open-label Clinical Trial with Levofloxacin, Omeprazole, Alinia (Nitazoxanide), and
Doxycycline (LOAD) versus Lansoprazole, Amoxicillin and Clarithromycin (LAC) in the
treatment naive Helicobacter pylori population – accepted for Oral presentation at President’s
plenary session of The American College of Gastroenterology Meeting, San Diego, CA to be
held from 23-28 October 2009.
Basu, P Patrick; Rayapudi, Krishna; Pacana, Tommy; Ramamurthy, Sindhu; A Randomized
Open-label Clinical Trial with Levofloxacin, Omeprazole, Alinia (Nitazoxanide), and
Doxycycline (LOAD) versus Lansoprazole, Amoxicillin and Clarithromycin (LAC) in the
treatment naive Helicobacter pylori population – Oral presentation done by T Pacana at Third
Ditan International Conference on Infectious Diseases held at Beijing, China from 30 July - 2
Aug , 2009
Basu, P Patrick; Rayapudi, Krishna; Pacana, Tommy; Ramamurthy, Sindhu; A Randomized
Open-label Clinical Trial with Levofloxacin, Omeprazole, Alinia (Nitazoxanide), and
Doxycycline (LOAD) versus Lansoprazole, Amoxicillin and Clarithromycin (LAC) in the
treatment naive Helicobacter pylori population – Oral presentation done by P Basu at
Digestive Disease Week – May 2009,Chicago
P Patrick Basu CV
21
P Patrick Basu; Krishna Rayapudi; Tommy Pacana; Sindhu Ramamurthy; Robert brown Jr; A
randomized open label clinical trial with Alpha lipoic acid and Vitamin E in Non-alcoholic
fatty liver disease – Oral presentation done by P Basu at Asia Pacific Association for Study of
Liver Disease Meeting , Hong Kong February 13-16, 2009
P Patrick Basu, Krishna Rayapudi, Jose Esteves, Robert Brown; A Pilot Study Utilizing
Nitazoxanide for Hepatic Encephalopathy in Chronic Liver Failure, Oral presentation done by
K Rayapudi at United European Gastroenterology Week, October 2008, Vienna, Austria
P Basu, K Rayapudi, J Esteves, T Crook; Mucosal Mastocytosis as a Histological Marker in
Diarrhea Predominant Irritable Bowel Syndrome, Oral Presentation done by K Rayapudi at
Asia Pacific Digestive Week Meeting, September 2008, New Delhi, India
Grand Round Lectures
Chronic Constipation; Peninsula General Hospital, NY March 2nd
2011 ,
Recent Updates on Hepatitis C Virus; March 2, 2011; North Shore LIJ- Manhasset;
Manhasset, NY
Recent Updates on Helicobacter Pylori; February 23, 2011; North Shore LIJ-Forest Hills,
Forest Hills, NY
Fatty Liver; December 14, 2010; All India Institute of Medical Sciences (AIIMS), India
Hepatitis C; December 26-28, 2010 ; Botanicals in Integrated Health Care, India
Fatty Liver; Indian Postgraduate Medical Education and Research (IPGMER), India Dec 26th
2010 .
Long-Term Considerations in Chronic Hepatitis B (CHB); May 12, 2010, New York Methodist
Hospital, Brooklyn, NY
Fatty Liver Disease, April 28, 2010, Columbia Presbetarian Hospital
Cirrhosis of liver and its complications
Jan 13, 2010, North Shore university hospital Forest hills
Helicobactor Pylori recent update 2010
Jan 24, 2010 – N Y Hospital Queens
NAFLD/NASH
August 18, 2009 – Fellows Grand Round Lecture, NSLIJ Hospital
Cirrhosis of liver and its complications ; April 2009 Medical grand rounds NY hospital of
queens NY
Cirrhosis and its Complications
March 3, 2009 – Fellows Grand round Lecture, NSLIJ Hospital
Iron Overload and Hemochomatosis
Jan 7, 2009 - Forest Hills Hospital
Evidenced based evaluation of liver function tests
Dec 9th 2008 - NY Hospital Queens
Update on Hepatitis B
November 2008 - SUNY Down State, New York
Non Alcoholic Steato Hepatitis
October 2008 - Brooklyn Hospital NY
Hepatitis B - Recent Update
P Patrick Basu CV
22
October 24, 2008 - GI Grand Rounds - SUNY Downstate Medical Center
Biologics in IBD
October 22, 2008 - GI Grand Rounds - New York Hospital Queens
New Horizons in Hepatitis C Treatment
October 14, 2008 – Medical Grand Rounds - New York Hospital Queens
Controversies and Future Management of Chronic Hepatitis-C
July 21, 2008 – Grand Rounds – St. Vincent’s Hospital New York, NY
Iron Homeostasis and Hemochromatosis
April 11, 2008 – Grand Rounds - Methodist Hospital, Brooklyn, New York
Fatty Liver Disease
March 28, 2008 – Grand Rounds - Mt.Sinai School of Medicine, New York, NY
Iron Homeostasis and Hemochromatosis
March 7th 2008 – Grand Rounds - Brookdale Hospital, Brooklyn, New York
Iron Homeostasis and Hemochromatosis
February 27th 2008 – Grand Rounds - New York Hospital, Queens, New York
Recent Advances in Hepatitis B
Jan 30th 2008 – Grand Rounds North Shore University Hospital at Forest Hills
Recent Updates on Chronic Hepatitis B
December 2007 – G/I Grand Rounds – Brooklyn Hospital, Brooklyn, NY
Alcohol, Alcoholism and Alcohol Related Liver Disease
December 2007 – G/I Grand Rounds - NY Hospital Queens, Queens, NY
Acute Liver Failure
December 2007 – Medical Grand Rounds - Bronx VA Medical Center, Bronx, NY
Hepatitis-C Recent Update
March 2007 – Medical Grand Rounds – Peninsula General Hospital,Brooklyn, NY
Acute Liver Failure
March 2007 – Medical Grand Rounds –New York Hospital Queens
Chronic Hepatitis
January 2007 – Medical Grand Rounds – Brookdale Hospital, Brooklyn, NY
Acute Liver Failure
January 2007 – Medical Grand Rounds – North Shore University Hospital at Forest Hills
Fatty Liver Disease
August 2006 – Medical Grand Rounds – Brookdale Hospital, Brooklyn, NY
Fatty Liver Disease
July 2006 – Medical Grand Rounds – New York Hospital Queens
New Horizons in Chronic Hepatitis C
May 2006 – Medical Grand Rounds – New Parkway Hospital at Forest Hills
Fatty Liver and NASH
May 2006 – St. Vincent’s Hospital, Staten Island, NY
Alcohol Related Liver Disease
February 2006 – G/I Grand Rounds – Columbia-Presbyterian Medical Ctr.
Fatty Liver And Its Recent Management.
December 2005 - G/I Grand Rounds - NYHQ
New Insight On Future Management Of Hepatitis C.
September 2005 - North Shore University Hospital Forest Hills.
P Patrick Basu CV
23
Caribbean Symposium On Gastroenterology And Hepatology
1. Management Of G E R D And Its Complication.
2. Alcohol And Alcoholic Liver Disease.
October 2005 - Dominican Republic @ Porto Platta
Recent Advances And Management Of Portal Hypertension
November 2005 – G/I Grand Round - NY Methodist Hospital, Brooklyn, NY
Alcohol And Alcoholic Liver Disease at
September 2005 - Grand Round - New Parkway Hospital at Forest Hills
Portal Hypertension in the 21st Century
May 2005 - G/I Grand Rounds - Maimonedes Medical Center
Portal Hypertension in the 21st Century
April 2005 – G/I Grand Rounds - NYHQ
Alcohol And Alcohol Related Liver Disease.
January 2005 - Medical Grand Rounds – NYHQ
Primary Biliary Cirrhosis
September 2004 – G/I Grand Rounds – Westchester Medical Center
Primary Biliary Cirrhosis
June 2004 – Medical Grand Rounds – NSUHFH
Acute Liver Failure.
June 2004 – G/I Grand Rounds – Westchester Medical Center.
Treatment of Anemia in Chronic HCV on Interferon
02/18/02 – CME Grand Round – North Shore University Hospital at F.H.
New Treatment of Chronic Hepatitis B
10/2001 – Lenox Hill Hospital, New York, NY
Endoscopic Ultrasound – A Novel Modality in the New Millennium‖
1999 – All India Institute of Medical Science and Research, India
―Hepatitis C – A Silent Killer‖
1999 – Calcutta Medical Center and Research, Calcutta, India
―Recent Update on Hepatic Encephalopathy‖
1996 - Elmhurst General Hospital, Elmhurst, NY
1995 - La Guardia Hospital, Forest Hills, NY
1994 - Neurology Grand Round, Mt. Sinai Medical Center, New York, NY
―Hemachromatosis‖
1996 - North Shore University Hospital of Forest Hills, Forest Hills, NY
1996 - Bronx V.A. Medical Center, Bronx, NY
―Recent Update on Viral Hepatitis‖
1993 -New York Downtown Hospital, New York, NY
―Hepatocellular Carcinoma‖
1992 -New York Downtown Hospital, New York, NY
Miscellaneous
Advisory Board Member
P Patrick Basu CV
24
American Liver Foundation – NY Chapter
Gilead Sciences
Vertex HCV Professional Speaker Bureau
National Speaker for:
Gilead
Roche
Salix
Takada
UCB
Abbott
Three rivers
Santoris
Axcan
Schering Plough
Astra Zeneca
TAP
Bristol Myers
Novartis
References
Emmet B Keeffe MD
Emeritus Professor of Medicine
Former President of AGA and AASLD
Former Chief of Hepatology at Stanford University
Email: [email protected]
Robert S. Brown, Jr., MD, MPH
Frank Cardile Professor of Medicine and Surgery
Chief, Center for Liver Disease and Transplantation
Columbia University College of Physicians & Surgeons
New York Presbyterian, 622 West 168 Street, PH 14, New York, NY 10032
Phone: (212) 305-0662
Fax: (212) 305-9139
Email: [email protected]
Ira M. Jacobson, MD
Chief, Division of Gastroenterology and Hepatology
Vincent Astor Distinguished Professor of Clinical Medicine
Cornell University/New York Presbyterian Hospital, New York, NY
Arun Sanyal, MD
Professor of Medicine
Division chief dept of medicine and gastroenterology
P Patrick Basu CV
25
Virginia Common wealth university , Richmond VA
Email: [email protected]
Maurice Cerrulli, MD
Program Director, Gastroenterology Training Program
North Shore LIJ Hospital
Email: [email protected]
----------------------------------------------------------